Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
ADA sinks toward its latest lows as the broader crypto sell-off deepens. With Hoskinson’s cautions and liquidity fadi...
PetSmart confirms the closure of its lone San Francisco location as online shopping reshapes the pet retail landscape...
Bitcoin edges toward a pivotal support zone as options activity and on-chain data point to renewed downside risk. Coi...
Wells Fargo cuts Gartner's price target to $140 as macro volatility tied to geopolitical tensions and AI competition ...
XRP sits in a sitting volatility trap liquidity as liquidity dries up on major venues and derivatives dominate tradin...
As crypto cycles unfold, investors ask which asset is best placed for the next bull. This guide breaks down Bitcoin v...
As the 2026 tax season approaches, a niche tactic tied to short-term rentals is drawing attention from investors and ...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
Could Ethereum steal the spotlight from Bitcoin in the next three years? This guide lays out the case, the risks, and...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...
Fidelity’s Q1 2026 data show the average IRA balance climbing to $131,380 as contributions surge. Yet the gap between...